Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Commercial partnership development for RespiHeart in India

Reference number
Coordinator RespiHeart AB
Funding from Vinnova SEK 100 000
Project duration October 2024 - March 2025
Status Completed
Venture Medtech4Health: Competence Enhancement in SME
Call Medtech4Health: Competence Enhancement in Small Businesses 2024

Important results from the project

The aim was to initiate discussions with potential partners for product development and commercialization in India. Three sub-goals were achieved during the project: 1. Identification of potential medtech companies, in India 2. Online introductory meetings with prioritized companies 3. Physical meetings with 2-3 companies on site in India The overall goal, to reach a collaboration agreement for product development, remains to be realized. Ongoing follow-up from completed meetings has continued.

Expected long term effects

1. Product development in partnership 2. Commercial development, with a global focus 3. Continued research and development (RespiHeart´s core business) 4. IP development / extension of the RespiHeart method, with more parameters and stronger protection

Approach and implementation

The project was run in collaboration with Business Sweden and their team in India. The main work steps were: - Criteria for target companies - Identification and evaluation - Contacts - Booking and online meetings - Mutual evaluation, in some cases additional online meetings were carried out - Meeting booking and planning for implementation of physical meetings - Implementation of meetings - Ongoing follow-up and next steps The project followed the plan both in terms of time and content.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 9 May 2025

Reference number 2024-02097